Best Practice In A Change Management System
|
|
|
- Natalie Parks
- 10 years ago
- Views:
Transcription
1 Quality & Compliance Associates, LLC Best Practice In A Change Management System
2 President Quality & Compliance Associates, LLC
3 Change Control and Its Role in a Continuous Improvement Environment 3
4 Benefits of An Effective Change Control System. Structured and consistent approach towards managing change Documenting the details of change Routing of change requests to appropriate individuals/team for approvals Documentation of change approvals and implementation Maintenance of change history and easy retrieval of information Tracking changes effectively Demonstrate compliance to FDA regulations 4
5 Change As A Quality Tool ICH Q10 FDA Quality System Audit PIC/S Pharmaceutical Inspection Conventions EMEA Guidelines ISO Documents 5
6 ICH Q10 Innovation, continual improvement, the outputs of process performance and product quality monitoring and CAPA drive change. In order to evaluate, approve and implement these changes properly, a company should have an effective change management system. The change control process is critical to ensure that change is controlled and approved for all phases within the pharmaceutical environment. ICH 10 links key elements to the stage of the process life cycle. 6
7 Q10 Key Elements Quality risk management should be utilized to evaluate proposed changes. Proposed changes should be evaluated relative to the marketing authorization. Proposed changes should be evaluated by expert teams contributing the appropriate expertise and knowledge. After implementation, an evaluation of the change should be undertaken to confirm the change objectives were achieved and there were no adverse impact on product quality. 7
8 Q10 Application of Change Management System in Lifecycle Development Technology Transfer Product Discontinuation Commercial Manufacturing 8
9 FDA Drug Manufactruing Inspections Program Quality Systems Approach to Investigations Focuses on Six Quality System including: Quality Faclities and Equipment Materials Production Packaging and Labeling Laboratory 9
10 Key Elements of Each of the Systems Control System for Implementing Changes 10
11 PIC/S Pharmaceutical Inspection Convention 11
12 Pharmaceutical Inspection Convention CHANGE CONTROL 43. Written procedures should be in place to describe the actions to be taken if a change is proposed to a starting material, product component, process equipment, process environment (or site), method of production or testing or any other change that may affect product quality or reproducibility of the process. Change control procedures should ensure that sufficient supporting data are generated to demonstrate that the revised process will result in a product of the desired quality, consistent with the approved specifications. 44. All changes that may affect product quality or reproducibility of the process should be formally requested, documented and accepted. The likely impact of the change of facilities, systems and equipment on the product should be evaluated, including risk analysis. The need for, and the extent of, requalification and re-validation should be determined. 12
13 Start of A Change Control Evaluation 13
14 When Should A Change Control Process Begin? Change Control Development Technology Transfer Commercial Manufacturing Product Discontinuation 14
15 ONE POSSIBILITY 15
16 Development Change control should begin when the process is determined. Registration batches Clinical batches Batches used to support regulatory submissions. May be an abbreviated process. Depending on the point in the development process, flexibility in scope of changes and approval may be different. 16
17 Technology Transfer Movement from a development/r&d mode to a commercial manufacturing environment. Validation is implemented. Critical control parameters established and confirmed. If change is not controlled well during development then the technology transfer will become more difficult. 17
18 Discuss Some Transfer Pitfalls Solid Dose Forms Parenterals 18
19 Commercial Manufacturing Quality Facilities and Equipment Materials Production Packaging and Labeling Laboratory 19
20 Specifications Methods Document Equipment Packaging Processes Suppliers API Raw Material EXAMPLES OF CHANGE TYPES 20
21 Three Fundamental Questions What might go wrong? What is the likelihood (probability) it will go wrong? What are the consequences (severity)? 21
22 Questions To Ask Why is the change needed? Necessity Improvement Regulatory What quality systems are impacted? What are the regulatory implications? What are the product implications? Are there validation implications? Has there been an appropriate technical evaluation? What is the time frame for implementation? 22
23 Risk Assessment in the Change Control Process ICH 10 - Quality risk management should be utilized to evaluate proposed changes. 23
24 ICH Q9 Quality Risk Management 24
25 Risk Assessment Process ICH Q9 Model Initiate Quality Risk Management Process Risk Assessment Risk Identification Risk Analysis Risk Evaluation unacceptable Risk Control Risk Reduction Risk Acceptance Output / Result of the Quality Risk Management Process Risk Review Review Events 25
26 Process Risk Identification Risk Analysis Risk Evaluation 26
27 Risk Identification Identification of hazards such as critical controls points in a process. Evaluation of a process using risk assessments and historical evaluations. Answers the question What might go wrong 27
28 Risk Analysis Estimation of quantitative or quality risk associated with the defined hazard. Likelihood of its occurence. Affect on product safety. 28
29 Risk Evaluation Data is critical to evaluation!!! Data can be either qualitative or qualitative. Robustness and reliability of data is critical. Where are the data gaps and how can these gaps be remediated. How can risk factors be measured either in a variable format and in qualitative format. 29
30 Remember The Goal is to minimize risk and simply not to accept. The end result should be not only an evaluation but also the goal to minimize and control. 30
31 Risk Management Methodology Basic Risk Management facilitation methods Failure Mode Effects Analysis (FMEA) Failure Mode, Effects and Criticality Analysis (FMECA) Fault Tree Analysis (FTA) Hazard Analysis and Critical Control Points (HACCP) Hazard Operability Analysis (HAZOP) Preliminary Hazard Analysis (PHA) Risk Ranking and Filtering Supporting Statistical Tools 31 31
32 Basic Risk Management Facilitation Methods Flowcharts Check Sheets Process Mapping Cause and Effect Diagrams 32
33 Q10 Proposed changes should be evaluated relative to the marketing authorization. Regulatory Affairs Determine impact of change to the regulatory filing Filing restrictions will determine when changes can be implemented. Assure that appropriate controls are in place. 33
34 Q10-Proposed changes should be evaluated by expert teams contributing the appropriate expertise and knowledge. Who Are the Experts? 34
35 Regulatory Affairs QA QC Others Potential Expert Team Members R&D Engineering Operations Information Technology Technical Services 35
36 Q10 - After implementation, an evaluation of the change should be undertaken to confirm the change objectives were achieved and there were no adverse impact on product quality. 36
37 Stages of A Change Control Proposal Acceptance Implementation Confirmation 37
38 Two of the Weakest Links is Either the Change Control is Not Done or It Is Not Implemented Appropriately 38
39 Success Stores and Their Challenges 39
40 Establishment of Change Control Within Organization Structures Example Initiator QA Change Control Committee CC Coordinator CC Committee Member 40
41 Initiator Assures compliance with process and procedure. Completes the appropriate documentation. Obtains the appropriate initial evaluations. Acts as the sponsor and facilitator of the CC. Presents the changes to the SME committee. 41
42 Change Control Coordinator Ensure that the documentation is complete Approves change for circulation. Reviews for duplication. Schedules meeting for change control committee. Publishes agenda and minutes for CC committee. Maintains CC database along with tracking. Maintains KPI s for CC. 42
43 Change Control Committee Member Performs technical evaluations for their respective areas. Approval completed documentation. Final approval of implementation confirmation. 43
44 QA Chair the CC Committee. Provide guidance on compliance and technical issues. Provide final review and sign-off for both the request and the completion of the change. 44
45 Key Performance Indicators Measure of success. Timeline compliance. Completion. Effectiveness Measures. Repetitiveness 45
46 Keep Metrics In Front of Senior Management i.e. Quality Council 46
47 Implementation of Change Control As a Quality System 47
48 Ways to Monitor and Track Changes List of changes maintained by a central area such as a change control coordination group. This should be one list. Electronic system such as trackwise or equivalent. Two critical elements to measure. Approval of request. Approval of completion or implementation segment. 48
49 Determination of Best Ways to Control Changes Corporate policy. Centralized control system within each site. Site gatekeepers. Tracking systems Verification system KPI Metrics 49
50 Examples of Change Control Organizations Such as Review Boards. Actual review board meetings. There can be scheduled meetings. Meetings as required. Referee systems. There may not be actual meetings. Electronic reviews Gatekeepers to coordinate questions. Initiator to answer questions. SME to provide guidance 50
51 Documentation Requirements for Change Control 51
52 How Many CC Procedures Does Your Organization Have? 52
53 General Types of Changes Documentation Raw Material Components Equipment Equipment Facility Utilities Computer System Process 53
54 Ensuring That Documentation Does Not Hinder the Process 54
55 TYPES OF FORMS Change proposal and initiation. Change implementation and approval. Verification. 55
56 Issues With Initiation Proposed change unclear Scope is too general or not defined. Actual change is not defined. Requirements not defined. Reason for change not clear. If change must be delayed due to completion of change requirements, tracking can become difficult without an appropriate system. 56
57 Quality Tool A good change control system will add value and should not be perceived as a hurdle to be avoided. There should be a group or individual to help expedite the CC process including the paperwork. The response from critical organizations such as regulatory affairs must be timely and decisions given quickly. Emergency changes should be minimal. 57
58 Verification and Control 58
59 Verification Tools to Confirm Appropriate Implementation Verification will be easier if the change control was concise with pre-determined acceptance criteria. QA is the final approver to determine that the event and system is working. Attempt to make success measureable. Validation execution. SOP completion. Training. Regulatory filings. Qualification 59
60 Roadblocks to Success Change control process is overly bureaucratic. Change controls lack supporting data. Changes are too nebulous and general. Measures to determine effectiveness are not predetermined. 60
61 Thank You Questions? 61
62 President Quality & Compliance Associates, LLC
Harmonizing Change Control Processes Globally
Quality & Compliance Associates, LLC Harmonizing Change Control Processes Globally President Quality & Compliance Associates, LLC When We Deal In A Global Environment, How Do We Design A System That Addresses
Quality Risk Management Tools Quality Risk Management Tool Selection When to Select FMEA: QRM Tool Selection Matrix
Quality Risk Management Tools Quality Risk Management Tool Selection When to Select FMEA: QRM Tool Selection Matrix 26 Quality Risk Management Tools The ICH Q9 guideline, Quality Risk Management, provides
QUALITY RISK MANAGEMENT (QRM): A REVIEW
Lotlikar et al Journal of Drug Delivery & Therapeutics; 2013, 3(2), 149-154 149 Available online at http://jddtonline.info REVIEW ARTICLE QUALITY RISK MANAGEMENT (QRM): A REVIEW Lotlikar MV Head Corporate
Guidance for Industry
Guidance for Industry Q9 Quality Risk Management U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation
Risk Assessment and Management. Allen L. Burgenson Manager, Regulatory Affairs Lonza Walkersville Inc.
Risk Assessment and Management Allen L. Burgenson Manager, Regulatory Affairs Lonza Walkersville Inc. Standard Disclaimer Standard Disclaimer: This presentation is the opinion of the presenter, and does
QUALITY RISK MANAGEMENT
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE QUALITY RISK MANAGEMENT Q9 Current Step 4 version
Quality Risk Management ICH Q9 & ISO 14971. Presented by Michael Kerr 11 th November 2011
Quality Risk Management ICH Q9 & ISO 14971 Presented by Michael Kerr 11 th November 2011 Agenda Risk Concept QRM Fundamentals Regulatory Expectations Warning Letters / Observations Application of QRM Introduction:
QA GLP audits. Alain Piton. Antipolis,, France. [email protected]
Risk based assessment applied to QA GLP audits Alain Piton Galderma R&D, Sophia-Antipolis Antipolis,, France [email protected] RISK BASED ASSESSMENT FOR GLP AUDITS INTRODUCTION Since the origin
Quality Risk Management Understanding and Control the Risk in Pharmaceutical Manufacturing Industry
International Journal of Pharmaceutical Science Invention ISSN (Online): 2319 6718, ISSN (Print): 2319 670X Volume 4 Issue 1 January 2015 PP.29-41 Quality Risk Management Understanding and Control the
Application of Quality Risk Management to Pharmaceutical Operations. Eldon Henson, Vice President, Quality Operations
Application of Quality Risk Management to Pharmaceutical Operations Eldon Henson, Vice President, Quality Operations Key Topics of Discussion Definition of Quality Risk Management (QRM) Overview of PDA
Quality Risk Management in Pharmaceutical Industry: A Review
International Journal of PharmTech Research CODEN (USA): IJPRIF ISSN : 0974-4304 Vol.6, No.3, pp 908-914, July-Aug 2014 Quality Risk Management in Pharmaceutical Industry: A Review V Vijayakumar Reddy*,
Improved Utilization of Self-Inspection Programs within the GMP Environment A Quality Risk Management Approach
Improved Utilization of Self-Inspection Programs within the GMP Environment A Quality Risk Management Approach Barbara Jeroncic Self-inspection is a well-established and vital part of the pharmaceutical
Annex 2. WHO guidelines on quality risk management. 1. Introduction 62. 2. Glossary 67 3. Quality risk management process 70
Annex 2 WHO guidelines on quality risk management 1. Introduction 62 1.1 Background and scope 62 1.2 Principles of quality risk management 64 2. Glossary 67 3. Quality risk management process 70 3.1 Initiating
Risk Assessment for Medical Devices. Linda Braddon, Ph.D. Bring your medical device to market faster 1
Risk Assessment for Medical Devices Linda Braddon, Ph.D. Bring your medical device to market faster 1 My Perspective Work with start up medical device companies Goal: Making great ideas into profitable
Optimizing Quality Control / Quality Assurance Agents of a Global Sourcing / Procurement Strategy
Optimizing Quality Control / Quality Assurance Agents of a Global Sourcing / Procurement Strategy Global Pharma Sourcing Conference December 6-7, 2011 Philadelphia, USA Nigel J. Smart, Ph.D. Smart Consulting
Quality Risk Management The Pharmaceutical Experience Ann O Mahony Quality Assurance Specialist Pfizer Biotech Grange Castle
Quality Risk Management 11 November 2011 Galway, Ireland Quality Risk Management The Pharmaceutical Experience Ann O Mahony Quality Assurance Specialist Pfizer Biotech Grange Castle Overview Regulatory
Conducting a Gap Analysis on your Change Control System. Presented By Miguel Montalvo, President, Expert Validation Consulting, Inc.
Conducting a Gap Analysis on your Change Control System Presented By Miguel Montalvo, President, Expert Validation Consulting, Inc. Standards, Regulations, Guidelines related to Change Control Management
Pharmaceutical Quality Systems: US Perspective
Pharmaceutical Quality Systems: US Perspective Rick Friedman Associate Director, Office of Manufacturing and Product Quality Center for Drug Evaluation and Research Topics Background: The ICH Q10 Pharmaceutical
ICH Q9 Quality Risk Management - an industry view. Peter H. Gough, Eli Lilly and Company
ICH Q9 Quality Risk Management - an industry view Peter H. Gough, Eli Lilly and Company Contents How did we get here? FDA 21 st Century GMP Initiative ICH activity Introduction to risk management Links
Quality Risk Management
PS/INF 1/2010 * * Quality Risk Management Quality Risk Management Implementation of ICH Q9 in the pharmaceutical field an example of methodology from PIC/S Document > Authors: L. Viornery (AFSSAPS) Ph.
Quality Risk Management Principles and Industry Case Studies
Final Draft Rev. December 28, 2008 Quality Risk Management Principles and Industry Case Studies T. Frank 1, S. Brooks 2, R. Creekmore 3, B. Hasselbalch 4, K. Murray 5, K. Obeng 6, S. Reich 5, E. Sanchez
Guidance for Industry: Quality Risk Management
Guidance for Industry: Quality Risk Management Version 1.0 Drug Office Department of Health Contents 1. Introduction... 3 2. Purpose of this document... 3 3. Scope... 3 4. What is risk?... 4 5. Integrating
International GMP Requirements for Quality Control Laboratories and Recomendations for Implementation
International GMP Requirements for Quality Control Laboratories and Recomendations for Implementation Ludwig Huber, Ph.D. [email protected] Overview GMP requirements for Quality Control laboratories
FMEA and FTA Analysis
FMEA and FTA Analysis Why it is Coming to Your Hospital and Your Laboratory Tina A. Krenc Director, R&D Phase Systems Abbott Laboratories 1 Agenda Background on requirements for risk management Tools to
Empowering the Quality and Regulatory Compliance Functions
Empowering the Quality and Regulatory Compliance Functions Management must take steps to ensure that regulatory and quality compliance is everyone s responsibility. By: J. Glenn George, Kenneth Imler,
3.0 Risk Assessment and Analysis Techniques and Tools
3.0 Risk Assessment and Analysis Techniques and Tools Risks are determined in terms of the likelihood that an uncontrolled event will occur and the consequences of that event occurring. Risk = Likelihood
IVD Regulation Overview. Requirements to Assure Quality & Effectiveness
IVD Regulation Overview Requirements to Assure Quality & Effectiveness CLIAC Jan. 2002 Statutory and Regulatory Requirements Statute: Food, Drug, and Cosmetic Act Food and Drugs Act of 1906 Food and Drug
PHARMACEUTICAL QUALITY SYSTEM Q10
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE PHARMACEUTICAL QUALITY SYSTEM Q10 Current Step
Quality Management System (QMS) for Active Pharmaceutical Ingredients (API) Manufacturers
Quality Management System (QMS) for Active Pharmaceutical Ingredients (API) Manufacturers integrating GMP (ICH Q7a) into ISO (9001: 2000) September 2005 Quality Management System - integrating GMP (ICH
Impact Assessment in a Science & Risk Based Environment. R. Legland 11/04/11
Impact Assessment in a Science & Risk Based Environment R. Legland 11/04/11 Background US GMP s EU GMP s Japan GMP s ICH Q8, Q9, Q10 Guidance ASTM Standard E2500-07 Science and Risk Based Approach to Determine
The Effective Management of Change Across the ICHQ10 Lifecycle
The Effective Management of Change Across the ICHQ10 Lifecycle Rob Hughes AstraZeneca 1 Change Management the guide This presentation will: describe a structured approach to change across the ICH Q10 lifecycle
The use of risk assessment tools for microbiological assessment of cleanroom environments. by Tim Sandle
The use of risk assessment tools for microbiological assessment of cleanroom environments by Tim Sandle Email: [email protected] / [email protected] Web: www.pharmig.blogspot.com Environmental
Corrective and Preventive Actions
Corrective and Preventive Actions A Five Step Approach Topics to Be Covered What is CAPA? Governing authority Five steps to a good CAPA process Where companies have difficulty Example citations Recap What
ICH Q10 Pharmaceutical Quality System (PQS)
ICH Q10 Pharmaceutical Quality System (PQS) International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use ICH Q10 PQS Guideline Background Objectives
How CMOs are Turning Their Training Programs into Market Differentiators
How CMOs are Turning Their Training Programs into Market Differentiators How CMOs are Turning Their Training Programs into Market Differentiators A Contract Manufacturing Organization (CMO) has as much
Implementing New USP Chapters for Analytical Method Validation
Implementing New USP Chapters for Analytical Method Validation March 2010 Ludwig Huber Fax.: +49 7243 602 501 E-mail: [email protected] Today s Agenda Handling Method Changes vs. Adjustments
3rd ANNUAL SEMINAR PHARMASSIST Ltd in collaboration with PHARMA D&S Srl
Venue: To be announced 3rd ANNUAL SEMINAR Quality Risk Management & Quality Risk Management (ICH Q9) & Applications in the Pharmaceutical Quality System (ICH Q10): Applications in the Pharmaceutical Sector
Best Practices In Ensuring Quality Standards When Outsourcing To Contract Manufacturers, Licensees And Consultants
Best Practices In Ensuring Quality Standards When Outsourcing To Contract Manufacturers, Licensees And Consultants Alex D. Kanarek, PhD BioProcess Technology Consultants, Inc. Strategic Institute Quality
Guidance for Industry. Q10 Pharmaceutical Quality System
Guidance for Industry Q10 Pharmaceutical Quality System U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation
Corrective and Preventive Action Background & Examples Presented by:
Corrective and Preventive Action Background & Examples Presented by: Kimberly Lewandowski-Walker Food and Drug Administration Division of Domestic Field Investigations Office of Regulatory Affairs Overview
COMPLIANCE BY DESIGN FOR PHARMACEUTICAL QUALITY CONTROL LABORATORIES INSIGHT FROM FDA WARNING LETTERS
COMPLIANCE BY DESIGN FOR PHARMACEUTICAL QUALITY CONTROL LABORATORIES INSIGHT FROM FDA WARNING LETTERS Primer CONTENTS INTRODUCTION...3 QUALITY AND COMPLIANCE IN QUALITY CONTROL LABORATORIES...5 Compliance
RISK MANAGEMENT FOR INFRASTRUCTURE
RISK MANAGEMENT FOR INFRASTRUCTURE CONTENTS 1.0 PURPOSE & SCOPE 2.0 DEFINITIONS 3.0 FLOWCHART 4.0 PROCEDURAL TEXT 5.0 REFERENCES 6.0 ATTACHMENTS This document is the property of Thiess Infraco and all
Working with ICH Quality Guidelines - the Canadian Perspective
Working with ICH Quality Guidelines the Canadian Perspective Krishnan Tirunellai, Ph. D. Bureau of Pharmaceutical Sciences Therapeutic Products Directorate Health Canada December 3, 2008 Outline Introduction
EU GMP Requirements - Quality Systems - Bernd Boedecker GMP Inspectorate of Hannover / Germany at Turkish Ministry of Health Ankara, 20-21 Oct 2009
EU GMP Requirements - Quality Systems - Bernd Boedecker GMP Inspectorate of Hannover / Germany at Turkish Ministry of Health Ankara, 20-21 Oct 2009 contact data Bernd Boedecker Staatliches Gewerbeaufsichtsamt
Commercial Manufacturing - Qualification & Validation-related GMP Deficiencies and Other Lifecycle Considerations
Commercial Manufacturing - Qualification & Validation-related GMP Deficiencies and Other Lifecycle Considerations Kevin O Donnell PhD Market Compliance Manager, IMB PDA / FDA Conference Pharmaceutical
WHITEPAPER: SOFTWARE APPS AS MEDICAL DEVICES THE REGULATORY LANDSCAPE
WHITEPAPER: SOFTWARE APPS AS MEDICAL DEVICES THE REGULATORY LANDSCAPE White paper produced by Maetrics For more information, please contact global sales +1 610 458 9312 +1 877 623 8742 [email protected]
Overview of EAM Services. A Fully Integrated Global EAM Service Provider
A Fully Integrated Global EAM Service Provider Table of Contents Strategy & Process Services Overview... p. 3 Asset Reliability Services Overview... p. 4 Systems & Technology Services Overview... p. 7
TEMPLATE DATA MANAGEMENT PLAN
TEMPLATE DATA MANAGEMENT PLAN ICRIN (QM sub group) Version: XX Date: XXXXXXX Page 1 of 6 1.0 Document Ownership The Data Management Plan (DMP) will be initiated and subsequently owned by the Data Manager
European Forum for Good Clinical Practice Audit Working Party
European Forum for Good Clinical Practice Audit Working Party REVISION OF THE ENGAGE 1 AUDITING GUIDELINE. AN OPTIONAL GUIDELINE FOR GCP COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS AUDITING This document
Quality Assurance. Disclosure for Lilli Møller Andersen. No relevant financial relationships exist for any issue mentioned in this presentation
Quality Assurance Disclosure for Lilli Møller Andersen No relevant financial relationships exist for any issue mentioned in this presentation Agenda Quality Assurance Quality Management System Quality
Introduction to Q10 Pharmaceutical Quality System
ICH-GCG Asean Training Workshop on ICH Guidelines Q8,Q9 and Q10 (New Paradigm) Introduction to Q10 Pharmaceutical Quality System Georges FRANCE, Q- IWG Kuala Lumpur, Malaysia 26-28 July 2010 International
Guidance on Qualification of existing facilities, systems, equipment and utilities
QUALIFICATION_EXISTING_EQUIPMENT_FINAL page 1 / 16 1. Acknowledgement...3 2. Introduction...3 3. Scope...4 4. Regulatory requirements...4 5. Guidance...4 5.1 Risk Assessment... 4 5.2 Procedure... 7 5.3
GRADUATE CERTIFICATE IN GOOD MANUFACTURING PRACTICE (GMP) Plan your career for tomorrow and you will be ahead of your competitors
GRADUATE CERTIFICATE IN GOOD MANUFACTURING PRACTICE (GMP) Plan your career for tomorrow and you will be ahead of your competitors This course is a distance-learning program that will culminate in a Graduate
Managing Clinical Trial Risk: It's a Tough Job, But One Person Has To Do It
Managing Clinical Trial Risk: It's a Tough Job, But One Person Has To Do It Michael Macri, Director, Strategic Services, inventiv Health Clinical Sherry Merrifield, Director, Clinical Monitoring, inventiv
How to implement a Quality Management System
How to implement a Quality Management System This whitepaper will help you to implement a Quality Management System (QMS), based on Good Manufacturing Practice (GMP), ISO 9001 or ISO 13485 within your
The purpose of this Supplier Quality Standard is to communicate the expectations and requirements of Baxter Healthcare Corporation to its suppliers.
Supplier Quality Standard 1.0 Purpose The purpose of this Supplier Quality Standard is to communicate the expectations and requirements of Baxter Healthcare Corporation to its suppliers. These expectations
SUPPLIER QUALITY MANAGEMENT SYSTEM QUESTIONNAIRE
Company Name Street Address City, State, Zip code Phone Number Fax Company Website Email Address ORGANIZATION NAME PHONE NUMBER EMAIL ADDRESS President/CEO General Manager Engineering Manager Production
ICH guideline Q10 on pharmaceutical quality system
September 2015 EMA/CHMP/ICH/214732/2007 Committee for Human Medicinal Products Step 5 Transmission to CHMP May 2007 Transmission to interested parties May 2007 Deadline for comments November 2007 Final
Controlling Risks Risk Assessment
Controlling Risks Risk Assessment Hazard/Risk Assessment Having identified the hazards, one must assess the risks by considering the severity and likelihood of bad outcomes. If the risks are not sufficiently
Aligning Quality Management Processes to Compliance Goals
Aligning Quality Management Processes to Compliance Goals MetricStream.com Smart Consulting Group Joint Webinar February 23 rd 2012 Nigel J. Smart, Ph.D. Smart Consulting Group 20 E. Market Street West
The FDA recently announced a significant
This article illustrates the risk analysis guidance discussed in GAMP 4. 5 By applying GAMP s risk analysis method to three generic classes of software systems, this article acts as both an introduction
IFS Food Safety and Quality Management System
This is an ideal package for Food Manufacturers looking to meet the requirements of the IFS Food Standard for quality and food safety of food products. Ensure your Food Safety & Quality Management System
Risk-Based Validation of Commercial Off-the-Shelf Computer Systems
Risk-Based Validation of Commercial Off-the-Shelf Computer Systems Published by Advanstar Communications in Journal of Validation Technology May 2005, Vol. 11, No. 3 Supplied by (*) www.labcompliance.com
Risk-Based Validation of Computer Systems Used In FDA-Regulated Activities
September 2, 2003 Risk-Based Validation of Computer Systems Used In FDA-Regulated Activities Purpose This document provides a summary of the requirements relating to use of computer-based systems in activities
UNICEF s Quality Assurance System for Procurement of Micronutrient Powders (MNP)
UNICEF s Quality Assurance System for Procurement of Micronutrient Powders (MNP) Nutrition Supplier Meeting, June 30, 2015 Dimitris Catsoulacos Quality Assurance Specialist PRESENTATION OVERVIEW Quality
Overview of Medical Device Design Controls in the US. By Nandini Murthy, MS, RAC
Overview of Medical Device Controls in the US By Nandini Murthy, MS, RAC 18 controls are a regulatory requirement for medical devices. In the US, compliance with the design controls section of 21 Code
Survey Results on The Structure of Medical Device Firms Quality/Regulatory/Compliance Functions
Survey Results on The Structure of Medical Device Firms Quality/Regulatory/Compliance Functions Nancy Singer Compliance-Alliance LLC www.compliance-alliance.com [email protected] Survey Results
What is Process Validation?
What is Process Validation? Process Validation is defined as the collection and evaluation of data, from the process design stage throughout production, which establishes scientific evidence that a process
Barnett International and CHI's Inaugural Clinical Trial Oversight Summit June 4-7, 2012 Omni Parker House Boston, MA
Barnett International and CHI's Inaugural Clinical Trial Oversight Summit June 4-7, 2012 Omni Parker House Boston, MA This presentation is the property of DynPort Vaccine Company LLC, a CSC company, and
Pharmaceutical Quality Management System: Current Concept
Pharmaceutical Quality Management System: Current Concept Neetu Dubey 1, *, Himanshu Gupta 3, R.K. Sharma 2, Nitin Dubey 1, Nidhi Dubey 4 1. IPS Academy, Indore, Madhya Pradesh, India. 2. Prestige Institute
PROPOSED UPDATED TEXT FOR WHO GOOD MANUFACTURING PRACTICES FOR PHARMACEUTICAL PRODUCTS: MAIN PRINCIPLES (JANUARY 2013)
January 2013 RESTRICTED PROPOSED UPDATED TEXT FOR WHO GOOD MANUFACTURING PRACTICES FOR PHARMACEUTICAL PRODUCTS: MAIN PRINCIPLES (JANUARY 2013) DRAFT FOR COMMENTS Please address any comments on this proposal
Validation Consultant
Personal Data Name Title Validation Consultant Contact jsb-validierung Zwischen den Bächen 9 D 79618 Rheinfelden Tel: +49 7623 79 49 82 Mobile: +49 172 737 84 86 E-Mail: Internet: [email protected] http://www.jsb-validierung.de
ASSESSMENT OF QUALITY RISK MANAGEMENT IMPLEMENTATION
PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PI 038-1 26 March 2012 AIDE-MEMOIRE ASSESSMENT OF QUALITY RISK MANAGEMENT IMPLEMENTATION PIC/S March 2012 Reproduction
Quality Risk Management - The Medical Device Experience. Niamh Nolan Principal Design Assurance Engineer Boston Scientific
Quality Risk Management - The Medical Device Experience Niamh Nolan Principal Design Assurance Engineer Boston Scientific Agenda Intent of Risk Management (RM) and Associated Regulations Overview of RM
With the introduction of GAMP 5, A
Online Exclusive from PHARMACEUTICAL ENGINEERING The Official Magazine of ISPE January/February 2012, Vol. 32 No. 1 www.pharmaceuticalengineering.org Copyright ISPE 2012 This article presents the case
OPERATIONAL STANDARD
1 of 11 1. Introduction The International Safe Transit Association (ISTA), a non-profit association whose objective is to prevent product damage and excess packaging usage within the distribution environment.
Seminario SSFA. New Guideline on Good Pharmacovigilance Practice (GVP) Fare clic per modificare lo stile del sottotitolo dello schema
Seminario SSFA New Guideline on Good Pharmacovigilance Practice (GVP) Pharmacovigilance Systems and their Quality Systems Milano, 20th April 2012 GIULIA M. VALSECCHI The proposed GVP - Module 1 Guidance
Quality by Design (QbD) Overview
Quality by Design (QbD) Overview Gary Warren Director, Haemostasis and Thrombosis R&D October, 2015 CSL Behring Pty Ltd Broadmeadows, Victoria What is Quality by Design (QbD)? QbD is: A Quality System
GOOD DOCUMENTATION AND QUALITY MANAGEMENT PRINCIPLES. Vimal Sachdeva Technical Officer (Inspector), WHO Prequalification of Medicines Programme
GOOD DOCUMENTATION AND QUALITY MANAGEMENT PRINCIPLES Vimal Sachdeva Technical Officer (Inspector), WHO Prequalification of Medicines Programme Contents 1. Why good documentation is essential? 2. What constitutes
Library Guide: Pharmaceutical GMPs
Library Guide: Pharmaceutical GMPs Table of Contents Overview...3 Courses Listed by Functional Area... 4 Course Descriptions: A Step-by-Step Approach to Process Validation (PHDV79)... 7 A Tour of the FDA
Process Validation Guidance Requirements (FDA and EU Annex 15: Qualification and Validation)
Global CompliancePanel Knowledge, a Way Forward 2-day In-person Seminar: Process Validation Guidance Requirements (FDA and EU Annex 15: Qualification and Validation) Los Angeles, CA July 28th & 29th, 2016
ICH Q10 - Pharmaceutical Quality System
WCC PDA Dinner Meeting Jan 2012 ICH Q10 - Pharmaceutical Quality System Neil Wilkinson NSF-DBA www.nsf-dba.com ICHQ10.1 WCC PDA Dinner Meeting Jan 2012 Your Presenter Partner at NSF-DBA USA Training, Consultancy,
Pharma Change Control
Pharma Change Control Strategies for Successful Company-Wide Implementation From the Editors of The Executive Briefing Series Copyright 2013 by Washington Business Information Inc. All rights reserved.
The Concept of Quality in Clinical Research. Dorota Śwituła Senior Clinical Quality Assurance Advisor
The Concept of Quality in Clinical Research Dorota Śwituła Senior Clinical Quality Assurance Advisor 1 Agenda What is quality? How we define quality in clinical research? The standard components of a Quality
Medical Device Training Program 2015
Medical Device Training Introduction Supplementary training and education is often overlooked by medical device professionals until it is triggered by an upcoming FDA or Notified Body and/or ISO 13485
National Institute for Health Research Coordinated System for gaining NHS Permission (NIHR CSP)
National Institute for Health Research Coordinated System for gaining NHS Permission (NIHR CSP) Operating Manual Please check the CRN Website for the latest version. Version: 6.0 Status: Consultation in
Establishment of a Quality Systems approach to Clinical Site Management An Overview of Standard Operating Procedures (SOPs)
Establishment of a Quality Systems approach to Clinical Site Management An Overview of Standard Operating Procedures (SOPs) Cornelia Kamp, MBA Executive Director Strategic Initiatives Tim Hackett Director
Auditing HACCP Programs
Auditing HACCP Programs Roger Roeth Executive Technical Officer 2016 EAGLE Certification Group includes EAGLE Registrations Inc. and EAGLE Food Registrations Inc. 1 Overview This training is applicable
ASTRAZENECA GLOBAL POLICY QUALITY AND REGULATORY COMPLIANCE
ASTRAZENECA GLOBAL POLICY QUALITY AND REGULATORY COMPLIANCE THIS POLICY OUTLINES THE TOP LEVEL REQUIREMENTS TO SUPPORT PRODUCT QUALITY IN THE DEVELOPMENT, MANUFACTURE AND DISTRIBUTION OF ACTIVE PHARMACEUTICAL
ISO 22000 Food Safety Management System
This is an ideal package for Food Manufacturers looking to meet International Food Safety Standards. This system meets the requirements of International Standard ISO 22000:2005 for Food Safety Management
Computer System Validation - It s More Than Just Testing
Computer System Validation - It s More Than Just Testing Introduction Computer System Validation is the technical discipline that Life Science companies use to ensure that each Information Technology application
A Risk Management Standard
A Risk Management Standard Introduction This Risk Management Standard is the result of work by a team drawn from the major risk management organisations in the UK, including the Institute of Risk management
The Global Guideline for GCP Audit
The Global Guideline for GCP Audit Author: JSQA: Hiroyasu Yamashita, e-mail: [email protected] Reviewed and Acknowledged by: BARQA: Patricia Fitzgerald, e-mail: [email protected]
Implementing Lifecycle Validation Practices at Contract Manufacturing Organizations
Implementing Lifecycle Validation Practices at Contract Manufacturing Organizations This paper discusses the nuances of lifecycle validation implementation at contract manufacturing organizations (CMOs).
Life Sciences Product Development Artifacts Survey Results
Life Sciences Product Development Artifacts Survey Results White Paper About the Survey Seapine Software conducted this survey over a six-week period during the first quarter of 2011. A total of 150 respondents
1. Scope This SOP covers requirements for PHARMCO-AAPER s Quality Management System
Page 1 of 8 1. Scope This SOP covers requirements for PHARMCO-AAPER s Quality Management System 2. Application This Standard Operating Procedure applied to the entire Quality Management System as it relevant
Quality by Design Approaches to Analytical Methods -- FDA Perspective. Yubing Tang, Ph.D. FDA/CDER/ONDQA AAPS, Washington DC October 25, 2011
Quality by Design Approaches to Analytical Methods -- FDA Perspective Yubing Tang, Ph.D. FDA/CDER/ONDQA AAPS, Washington DC October 25, 2011 1 Outline What is Quality by Design (QbD) Role of Analytical
FINE LOGISTICS. Quality Manual. Document No.: 20008. Revision: A
FINE LOGISTICS Quality Manual Document No.: 20008 Revision: A 20008 Rev. A FINE LOGISTICS, Quality Manual Page 1 of 24 Quality Manual: Table of contents Number Section Page 1. GENERAL 3 1.1 Index and revision
Quality Management System Manual
Quality Management System Manual Assurance ISO / AS Manual Quality Management System EXCEEDING ALL EXPECTATIONS Since our inception in 1965, Swiss-Tech has supplied the medical, aerospace, hydraulic, electronic
Guidance for Industry: Starting Material Supplier Management
Guidance for Industry: Starting Material Supplier Management Version 1.0 Drug Office Department of Health. Contents 1. Introduction... 3 2. Purpose of this document... 3 3. Scope... 3 4. Selecting and
